SAN FRANCISCO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneer of AAV immuno-gene therapy for cancer, today revealed its lead asset, SRN-101, for the treatment of high-grade gliomas.
IRVINE, Calif., April 15, 2026 /PRNewswire/ -- Seragon Biosciences Inc. today announced the publication of comprehensive preclinical study results in the peer-reviewed journal Drug Design, Development ...
Anaheim, CA (September 28, 2015) – Samsung Techwin America continues to develop solutions that deliver maximum performance and value with the release of its new NVRs at ASIS 2015 (booth # 1729).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results